siRNA directed against TrkA sensitizes human pancreatic cancer cells to apoptosis induced by gemcitabine through an inactivation of PI3K/Akt-dependent pathway

Oncology Reports

Volumn 18, Issue 3, 2007, Pages 673-677

  Liu, Dapeng ^a   Zhang, Yong ^a   Dang, Chengxue ^a   Ma, Qingyong ^a   Lee, Woo ^b   Chen, Wuke ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Pancreatic cancer; PI3K Akt; siRNA; TrkA

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE; PROTEIN TYROSINE KINASE A; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CELL LINE, TUMOR; DEOXYCYTIDINE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PANCREATIC NEOPLASMS; RECEPTOR, TRKA; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 38449108441     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.3.673     Document Type: Article

References (20)

1. Gudjonsson B: Cancer of the pancreas. Fifty years of surgery. Cancer 60: 2284-2303, 1987.
2. Magistrelli P, Antinori A, Crucitti A, La Greca A, Masetti R, Coppola R, Nuzzo G and Picciocchi A: Prognostic factors after surgical resection for pancreatic carcinoma. J Surg Oncol 74: 36-40, 2000. (Pubitemid 30387220)
3. Burris HA III, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD and von Hoff DD: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15: 2403-2413, 1997. (Pubitemid 27251144)
4. Zhang Y, Dang C, Ma Q and Shimahara Y: Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer. Oncol Rep 14: 161-171, 2005.
5. Sanchez C, Clementi M, Benitez D, Contreras H, Huidobro C and Castellon E: Effect of GnRH analogs on the expression of TrkA and p75 neurotrophin receptors in primary cell cultures from human prostate adenocarcinoma. Prostate 65: 195-202, 2005. (Pubitemid 41443724)
6. Dolle L, El Yazidi-Belkoura I, Adriaenssens E, Nurcombe V and Hondermarck H: Nerve growth factor overexpression and autocrine loop in breast cancer cells. Oncogene 22: 5592-5601, 2003. (Pubitemid 37102695)
7. Lind DS, Hochwald SN, Malaty J, Rekkas S, Hebig P, Mishra G, Moldawer LL, Copeland EM III and Mackay S: Nuclear factor-kappa B is upregulated in colorectal cancer. Surgery 130: 363-369, 2001. (Pubitemid 32721692)
8. Nabhan C, Gajria D, Krett NL, Gandhi V, Ghias K and Rosen ST: Caspase activation is required for gemcitabine activity in multiple myeloma cell lines. Mol Cancer Ther 1: 1221-1227, 2002.
9. Xu ZW, Friess H, Buchler MW and Solioz M: Overexpression of Bax sensitizes human pancreatic cancer cells to apoptosis induced by chemotherapeutic agents. Cancer Chemother Pharmacol 49: 504-510, 2002. (Pubitemid 34671287)
10. Duxbury MS, Ito H, Benoit E, Zinner MJ, Ashley SW and Whang EE: RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity. Biochem Biophys Res Commun 311: 786-792, 2003. (Pubitemid 37377726)
11. Duxbury MS, Ito H, Zinner MJ, Ashley SW and Whang EE: siRNA directed against c-Src enhances pancreatic adenocarcinoma cell gemcitabine chemosensitivity. J Am Coll Surg 198: 953-959, 2004. (Pubitemid 38759847)
12. Collis SJ, Swartz MJ, Nelson WG and De Weese TL: Enhanced radiation and chemotherapy-mediated cell killing of human cancer cells by small inhibitory RNA silencing of DNA repair factors. Cancer Res 63: 1550-1554, 2003. (Pubitemid 36373642)
13. Wu H, Hait WN and Yang JM: Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells. Cancer Res 63: 1515-1519, 2003. (Pubitemid 36373637)
14. Chang IY, Kim MH, Kim HB, Lee DY, Kim SH, Kim HY and You HJ: Small interfering RNA-induced suppression of ERCC1 enhances sensitivity of human cancer cells to cisplatin. Biochem Biophys Res Commun 327: 225-233, 2005. (Pubitemid 40051375)
15. Eguchi M, Eguchi-Ishimae M, Tojo A, Morishita K, Suzuki K, Sato Y, Kudoh S, Tanaka K, Setoyama M, Nagamura F, Asano S and Kamada N: Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25). Blood 93: 1355-1363, 1999. (Pubitemid 29076151)
16. Reuther GW, Lambert QT, Caligiuri MA and Der CJ: Identification and characterization of an activating TrkA deletion mutation in acute myeloid leukemia. Mol Cell Biol 20: 8655-8666, 2000. (Pubitemid 32245899)
17. Shi Y: Mammalian: RNAi for the masses. Trends Genet 19: 9-12, 2003.
18. Zhou H, Li XM, Meinkoth J and Pittman RN: Akt regulates cell survival and apoptosis at a post-mitochondrial level. J Cell Biol 151: 483-494, 2000.
19. Bondar VM, Sweeney-Gotsch B, Andreeff M, Mills GB and McConkey DJ: Inhibition of the phosphatidylinositol 3′-kinase-AKT pathway induces apoptosis in pancreatic carcinoma cells in vitro and in vivo. Mol Cancer Ther 1: 989-997, 2002.
20. Ng SSW, Tsao MS, Chow S and Hedley DW: Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells. Cancer Res 60: 5451-5455, 2000.